acceleraze UG – Trademark Portfolio

Entity Type: 16

acceleraze UG holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 1 filings in this category. The portfolio also extends into Class 41 (Education & Entertainment) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include ACCELERAZE.

Maicklerstraße 11

70736 Fellbach

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

acceleraze UG's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

35
Advertising & Business (1 filing)

Advertising; business management; business administration; office functions

41
Education & Entertainment (1 filing)

Education; providing of training; entertainment; sporting and cultural activities

44
Medical Services (1 filing)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademarks does acceleraze UG have?

acceleraze UG has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does acceleraze UG file in?

acceleraze UG files trademarks across 3 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 41 (Education & Entertainment), Class 44 (Medical Services). Class 35 covers advertising; business management; business administration; office functions.

What are acceleraze UG's most well-known trademarks?

acceleraze UG's registered trademark portfolio includes well-known marks such as ACCELERAZE. These are among 1 currently registered trademark in the portfolio.

What is acceleraze UG's trademark registration success rate?

acceleraze UG has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.